💹 IPO Frenzy Next Week! Groww’s ₹6,632 Crore Issue Steals the Spotlight with 3 SME Offers & 5 Listings on Radar
As India’s IPO market continues its record-breaking momentum, the upcoming week promises another power-packed lineup for investors. With one blockbuster mainboard IPO and three SME offerings set to open, along with five new listings ready to hit the exchanges, the primary market is buzzing with excitement.
🚀 Mainboard IPO: Groww Leads the Charge
The clear headline-grabber is the Groww IPO, launched by Billionbrains Garage Ventures Pvt. Ltd., the parent company of the popular investing platform Groww.
The public issue, worth a whopping ₹6,632.30 crore, opens for bidding on November 4 and closes on November 7. The price band is set between ₹95–₹100 per share, with a lot size of 150 shares.
This IPO includes a fresh share sale worth ₹1,060 crore, while an offer for sale (OFS) of ₹5,572.30 crore will see early investors and promoters, including Peak XV Partners, Ribbit Capital, and YC Holdings, offload part of their holdings.
With Groww’s massive customer base and strong brand recall in India’s fast-growing fintech ecosystem, analysts expect strong investor demand — especially from retail and HNI participants.
📈 SME IPOs: Three New Offers on Deck
While Groww dominates the headlines, the SME segment remains equally vibrant, with three companies — Shreeji Global FMCG, Finbud Financial Services, and Curis Lifesciences — preparing to launch their public issues.
🏪 Shreeji Global FMCG IPO
This ₹85 crore issue opens on November 4 and closes on November 7. The IPO is entirely a fresh issue with a price band of ₹120–₹125 per share. Retail investors can apply in lots of 2,000 shares, and the company’s shares are set to list on NSE SME on November 12.
💰 Finbud Financial Services IPO
Finbud Financial Services’ ₹71.68 crore IPO opens on November 6 and closes on November 10, priced between ₹140–₹142 per share. This too is a fresh issue, with a likely listing date of November 13 on NSE SME.
⚗️ Curis Lifesciences IPO
Curis Lifesciences’ ₹27.52 crore public issue runs from November 7 to November 11, with a price band of ₹120–₹128 per share. Retail investors can subscribe in lots of 2,000 shares, and the listing is expected on November 14 on NSE SME.
🏁 IPO Buzz Continues
With these four new issues and five listings slated next week, investors have plenty of opportunities to explore. From the high-profile Groww IPO to smaller but promising SME listings, the market’s IPO momentum shows no signs of cooling.
Whether you’re a seasoned investor or a newcomer, next week’s IPO calendar offers something for everyone — from fintech growth stories to niche-sector opportunities.